Skip to main content
NVDA-2.58%AAPL+2.70%GOOGL+0.37%MSFT-0.15%AMZN-0.17%TSM-1.31%SPCX+0.82%AVGO-0.52%META-1.02%TSLA-0.63%SKHY-4.08%MU-4.41%BRK-B-0.24%LLY+0.15%JPM-0.63%WMT+0.08%AMD-3.01%V-0.18%XOM+0.68%ASMLa-1.66%JNJ-0.01%INTC-4.65%MA-0.56%0700.HK-1.94%1398.HK+0.79%ORCL-4.08%ABBV+0.89%BAC-0.49%CSCO-1.24%CVX-0.30%COST-0.21%KO+0.67%LRCX-4.89%CAT-1.36%AP2d-1.55%0005.HK-0.78%AMAT-2.37%UNH-0.63%HSBA.L-1.30%DELL-4.07%PG+0.35%MS-1.27%GE-0.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.09%HD-1.76%0939.HK+1.66%GS-1.31%NZDJPY-2.62%AUDJPY-1.83%CHFJPY-1.60%NZDCAD-1.48%EURNZD+1.47%NZDUSD-1.44%GBPNZD+1.41%GBPJPY-1.23%USDJPY-1.22%EURJPY-1.21%CADJPY-1.17%NZDCHF-1.06%USDZAR+1.03%USDSEK+0.91%USDNOK+0.90%EURZAR+0.86%AUDNZD+0.83%GBPZAR+0.77%EURSEK+0.74%EURNOK+0.74%AUDCAD-0.69%USDTHB+0.66%AUDDKK-0.66%EURAUD+0.63%AUDUSD-0.62%GBPAUD+0.58%CHFSEK+0.56%AUDSGD-0.56%CHFNOK+0.55%USDMXN+0.51%NZDSGD-0.45%USDPLN+0.43%CADCHF+0.42%GBPTRY+0.41%USDCHF+0.40%EURCHF+0.40%NOKJPY-0.38%GBPCHF+0.36%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.27%EURPLN+0.27%SGDJPY+0.25%AUDCHF-0.23%NZDMXN-0.23%EURHKD-0.17%USDDKK+0.16%USDILS+0.16%USDTRY+0.11%EURSGD+0.11%USDCNH+0.10%PLNJPY+0.09%GBPCAD-0.08%CHFSGD-0.08%AUDNOK+0.07%EURCZK-0.05%EURGBP+0.05%EURCNH-0.04%USDCOP-0.04%EURCAD-0.04%USDCAD-0.03%GBPUSD-0.02%USDHKD+0.02%GBPSGD+0.01%EURUSD0.00%EURDKK0.00%XPTUSD-6.02%UKOIL+5.13%XAGUSD-5.11%GAGUSD-5.11%USOIL+4.96%HG1-4.92%XNGUSD+1.70%GAUUSD-1.50%XAUUSD-1.50%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.57%ETHUSD-0.44%USDTUSD-0.03%XRPUSD-3.32%SOLUSD-2.20%TRXUSDT+0.15%ZECUSDT-9.76%DOGEUSD-3.10%XMRUSDT-0.40%LINKUSD-1.59%XLMUSD-1.74%BCHUSDT-10.46%LTCUSD-1.99%UNIUSD-1.71%TONUSD+24.88%HBARUSDT-2.45%SUIUSD-4.49%TAOUSDT-5.69%AAVEUSD-2.65%DOTUSDT-2.01%ICPUSDT-1.73%ONDOUSDT-3.56%WLDUSDT-3.63%ATOMUSDT-3.46%ARBUSDT-0.16%JUPUSDT-3.82%INJUSDT-2.88%STXUSDT-4.16%FETUSDT-3.62%TIAUSDT-1.39%PYTHUSDT-1.49%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.63%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.56%IOTAUSDT-3.83%AXSUSDT-2.47%FARTCOINUSDT-4.35%EOSUSDT-2.91%DYDXUSDT-2.55%ORDIUSDT-0.97%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.58%AAPL+2.70%GOOGL+0.37%MSFT-0.15%AMZN-0.17%TSM-1.31%SPCX+0.82%AVGO-0.52%META-1.02%TSLA-0.63%SKHY-4.08%MU-4.41%BRK-B-0.24%LLY+0.15%JPM-0.63%WMT+0.08%AMD-3.01%V-0.18%XOM+0.68%ASMLa-1.66%JNJ-0.01%INTC-4.65%MA-0.56%0700.HK-1.94%1398.HK+0.79%ORCL-4.08%ABBV+0.89%BAC-0.49%CSCO-1.24%CVX-0.30%COST-0.21%KO+0.67%LRCX-4.89%CAT-1.36%AP2d-1.55%0005.HK-0.78%AMAT-2.37%UNH-0.63%HSBA.L-1.30%DELL-4.07%PG+0.35%MS-1.27%GE-0.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.09%HD-1.76%0939.HK+1.66%GS-1.31%NZDJPY-2.62%AUDJPY-1.83%CHFJPY-1.60%NZDCAD-1.48%EURNZD+1.47%NZDUSD-1.44%GBPNZD+1.41%GBPJPY-1.23%USDJPY-1.22%EURJPY-1.21%CADJPY-1.17%NZDCHF-1.06%USDZAR+1.03%USDSEK+0.91%USDNOK+0.90%EURZAR+0.86%AUDNZD+0.83%GBPZAR+0.77%EURSEK+0.74%EURNOK+0.74%AUDCAD-0.69%USDTHB+0.66%AUDDKK-0.66%EURAUD+0.63%AUDUSD-0.62%GBPAUD+0.58%CHFSEK+0.56%AUDSGD-0.56%CHFNOK+0.55%USDMXN+0.51%NZDSGD-0.45%USDPLN+0.43%CADCHF+0.42%GBPTRY+0.41%USDCHF+0.40%EURCHF+0.40%NOKJPY-0.38%GBPCHF+0.36%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.27%EURPLN+0.27%SGDJPY+0.25%AUDCHF-0.23%NZDMXN-0.23%EURHKD-0.17%USDDKK+0.16%USDILS+0.16%USDTRY+0.11%EURSGD+0.11%USDCNH+0.10%PLNJPY+0.09%GBPCAD-0.08%CHFSGD-0.08%AUDNOK+0.07%EURCZK-0.05%EURGBP+0.05%EURCNH-0.04%USDCOP-0.04%EURCAD-0.04%USDCAD-0.03%GBPUSD-0.02%USDHKD+0.02%GBPSGD+0.01%EURUSD0.00%EURDKK0.00%XPTUSD-6.02%UKOIL+5.13%XAGUSD-5.11%GAGUSD-5.11%USOIL+4.96%HG1-4.92%XNGUSD+1.70%GAUUSD-1.50%XAUUSD-1.50%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.57%ETHUSD-0.44%USDTUSD-0.03%XRPUSD-3.32%SOLUSD-2.20%TRXUSDT+0.15%ZECUSDT-9.76%DOGEUSD-3.10%XMRUSDT-0.40%LINKUSD-1.59%XLMUSD-1.74%BCHUSDT-10.46%LTCUSD-1.99%UNIUSD-1.71%TONUSD+24.88%HBARUSDT-2.45%SUIUSD-4.49%TAOUSDT-5.69%AAVEUSD-2.65%DOTUSDT-2.01%ICPUSDT-1.73%ONDOUSDT-3.56%WLDUSDT-3.63%ATOMUSDT-3.46%ARBUSDT-0.16%JUPUSDT-3.82%INJUSDT-2.88%STXUSDT-4.16%FETUSDT-3.62%TIAUSDT-1.39%PYTHUSDT-1.49%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.63%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.56%IOTAUSDT-3.83%AXSUSDT-2.47%FARTCOINUSDT-4.35%EOSUSDT-2.91%DYDXUSDT-2.55%ORDIUSDT-0.97%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
IB

IDEAYA Biosciences, Inc. (IDYA)

NASDAQ • Healthcare

$38.35
-$0.49 (-1.3%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$39.19
Previous Close$38.35
Day Range$38.21 - $39.19
Avg. Volume (3M)715.8K
Market Cap$3.6B
52 Week Range
$24.24$42.68
Next EarningsIn 60 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$8.8M100%
Gross Profitminus cost of goods$8.8M100%

Fundamentals & Financials

Revenue (TTM)
$234.1M
Net Income (TTM)
-$175M
EPS (TTM)
-$1.92
ROA (TTM)
-13.36%
Current Ratio
10.45

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+1.2%Q1 2026-$0.94
-3.7%Q2 2026-$1.11
-15.1%Q3 2026-$1.22
Next

Nov 9

in 60 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is a biotechnology company focused on precision oncology, developing targeted cancer medicines for molecularly defined patient groups. In FY2025, it generated $218.7 million in revenue. The company centers its approach on synthetic lethality, using genetic and molecular diagnostic selection to match therapies to specific tumor vulnerabilities.

Name
IDEAYA Biosciences, Inc.
CEO
Yujiro S. Hata
Website
www.ideayabio.com
Industry
Healthcare
Year Founded
2015
Employees
145

Today's Snapshot

AI-generated

So far today, IDYA is trading slightly lower at 38.28, in line with a flat sector. IDEAYA Biosciences gave the first patient treatment in its OptimUM-11 cancer trial.

Trading Volume

Below 10d avg (606.8K)

183.8K

vs S&P 500 Today

Moderate Outperformance

+0.39%

Updated: September 10, 2026 at 16:46 UTC

Technical Indicators

4 Buy2 Neutral2 Sell
IDYA shows a constructive longer-term setup despite short-term softness: the stock is below its 10/20-day averages but remains above the 50/100/200-day moving averages, and oscillators such as stochastic and Williams %R are signaling short-term buying interest while RSI and MACD are neutral. ADX near 24 denotes modest trend strength and ATR around 3.4% indicates moderate volatility, though on-balance volume is weak and intraday VWAP sits slightly below current price. Technical takeaway: Buy — longer-term moving averages provide support amid mixed short-term momentum.
All signals
  • EMA (5 indicators)$34.04 - $39.27
    Buy
  • RSI (14)46.58
    Neutral
  • Stochastic %K (14, 3, 3)14.32
    Buy
  • MACD Level (12, 26)0.56
    Neutral

Peers & Related Assets

SRRKScholar Rock Holding Corporation
$54.62-4.9%
COGTCogent Biosciences, Inc.
$34.18-3.1%
ADPTAdaptive Biotechnologies Corporation
$24.42+0.3%
MLYSMineralys Therapeutics, Inc.
$30.5-2.0%
BEAMBeam Therapeutics Inc.
$25.17-6.2%
KNSAKiniksa Pharmaceuticals International, plc
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.